The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime.
Kyle C MolinaJeffrey F BarlettaScott T HallCyrus YazdaniVanthida HuangPublished in: Journal of intensive care medicine (2019)
The risk of AKI was similar between VPT and VC groups in critically ill patients. Risk factors for AKI were related to baseline renal function, duration of combination therapy, supratherapeutic vancomycin troughs, and severity of illness.